Table 2.
TSH | FT4 | FT3 | |||||||
---|---|---|---|---|---|---|---|---|---|
HR (95% CI) | P value | Pinteractiona | HR (95% CI) | P value | Pinteractiona | HR (95% CI) | P value | Pinteractiona | |
All-cause mortality | |||||||||
Total population nevents/ntotal = 380/6054 | |||||||||
Crude | 0.93 (0.84–1.03) | 0.18 | 1.29 (1.17–1.42) | <0.001 | 0.88 (0.78–1.00) | 0.05 | |||
Age- and sex-adjusted | 0.99 (0.90–1.10) | 0.89 | 0.90 | 1.24 (1.13–1.37) | <0.001 | 0.03 | 0.99 (0.89–1.09) | 0.81 | 0.002 |
Multivariable modelb | 1.02 (0.92–1.14) | 0.65 | 0.87 | 1.18 (1.07–1.30) | 0.001 | 0.01 | 0.99 (0.89–1.10) | 0.81 | 0.006 |
Men nevents/ntotal = 288/3149 | |||||||||
Crude | 0.97 (0.85–1.09) | 0.58 | 1.10 (0.99–1.24) | 0.09 | 0.60 (0.51–0.70) | <0.001 | |||
Age-adjusted | 1.00 (0.89–1.13) | 0.99 | 1.17 (1.04–1.31) | 0.007 | 0.91 (0.78–1.07) | 0.25 | |||
Multivariable modelc | 1.00 (0.89–1.14) | 0.95 | 1.14 (1.01–1.27) | 0.03 | 0.92 (0.79–1.07) | 0.27 | |||
Women nevents/ntotal = 92/2905 | |||||||||
Crude | 1.00 (0.82–1.22) | 0.99 | 1.68 (1.37–2.05) | <0.001 | 1.11 (0.99–1.24) | 0.08 | |||
Age-adjusted | 0.99 (0.82–1.19) | 0.89 | 1.56 (1.28–1.90) | <0.001 | 1.18 (1.05–1.32) | 0.005 | |||
Multivariable modelc | 1.07 (0.89–1.30) | 0.47 | 1.47 (1.19–1.82) | <0.001 | 1.18 (1.02–1.35) | 0.02 | |||
Cardiovascular mortality | |||||||||
Total population nevents/ntotal = 103/6054 | |||||||||
Crude | 0.89 (0.73–1.09) | 0.26 | 1.40 (1.16–1.69) | <0.001 | 0.73 (0.57–0.93) | 0.01 | |||
Age- and sex-adjusted | 0.97 (0.79–1.18) | 0.75 | 0.87 | 1.34 (1.11–1.61) | 0.002 | 0.40 | 0.86 (0.66–1.12) | 0.27 | 0.46 |
Multivariable modelb | 0.98 (0.80–1.20) | 0.86 | 0.84 | 1.23 (1.02–1.49) | 0.03 | 0.22 | 0.91 (0.70–1.18) | 0.48 | 0.67 |
Men nevents/ntotal = 83/3149 | |||||||||
Crude | 0.92 (0.72–1.16) | 0.48 | 1.21 (0.98–1.49) | 0.07 | 0.50 (0.37–0.67) | <0.001 | |||
Age-adjusted | 0.96 (0.77–1.21) | 0.73 | 1.29 (1.04–1.59) | 0.02 | 0.83 (0.61–1.13) | 0.27 | |||
Multivariable modelc | 0.93 (0.73–1.18) | 0.56 | 1.23 (1.00–1.52) | 0.05 | 0.87 (0.64–1.18) | 0.38 | |||
Women nevents/ntotal = 20/2905 | |||||||||
Crude | 1.02 (0.67–1.55) | 0.93 | 1.82 (1.19–2.78) | 0.005 | 0.92 (0.53–1.61) | 0.78 | |||
Age-adjusted | 1.00 (0.67–1.50) | 0.99 | 1.61 (1.07–2.42) | 0.02 | 1.02 (0.59–1.76) | 0.95 | |||
Multivariable modelc | 1.17 (0.77–1.78) | 0.47 | 1.46 (0.92–2.31) | 0.10 | 0.96 (0.54–1.70) | 0.89 |
Point estimates are expressed per SD increment in the predictor
CI confidence interval, FT3 free triiodothyronine, FT4 free thyroxine, HR hazard ratio, TSH thyrotropin
aEvidence against the null hypothesis of no effect modification by sex on the association of the thyroid function parameter and the specific outcome concerned
bAdjusted for age, sex, current smoking, body-mass index, systolic blood pressure, use of antihypertensive drugs, total cholesterol/high-density lipoprotein ratio, ln triglycerides, use of lipid-lowering drugs, type 2 diabetes, high-sensitive C-reactive protein, history of cardiovascular disease, estimated glomerular filtration rate, and ln urinary albumin excretion
cAdjusted for all potential confounders except for sex